Pathwork Diagnostics
Recent Finacing
Series C
Recent Raise
$30M
Pathwork Diagnostics develops molecular oncology diagnostics, including the FDA-cleared Tissue of Origin Test that identifies cancer sources from FFPE tissue and integrates with clinical history and complementary diagnostics.
Highlights
Focus Areas
Biotechnology
Genetics
Health Care
Health Diagnostics
Oncology
Recent Investors
Financials
$50M
Total Raised
2
Funding rounds
7
Investors